Company Description: BioMarin, Shire, Genzyme, Hyperion, Synageva, Swedish Orphan-Biovitrum, SOBI, Sarepta, Prosensa, PTC Therapeutics and Ultragenyx, biotech, biotechnology, pharmaceutical, biologic, small molecule, drugs, rare disease, orphan product, ultra rare disease, enzyme, enzyme replacement therapy, triheptanoin, krn23, rhGUS, sialic acid, SA-ER, XLH, x-linked hypophosphatemia, MPS VII, MPS 7, mucopolysaccharidosis, sly disease, sly syndrome, FAOD, Glut1 Deficiency Syndrome, HIBM, hereditary inclusion body myopathy, GNE myopathy, C7, rickets, renal phosphate, DMRV, Nonaka disease, De Vivo disease, LCHAD, CPT2, VLCAD, TFP, CACT, CTD, MCAD, clinical trials, drug development, Emil Kakkis, metabolic, inborn errors of metabolism, muscle wasting, myopathy, myositis, distal myopathy with rimmed vacuoles, anti-FGF23, monoclonal antibody, UX001, UX003, UX007, UK007G, UX023, bone deformity, osteomalacia, microfractures, fatty acid oxidation disorders, galactosialidosis, epilepsy, absence seizures, substrate replacement, vitamin D-resistant rickets, lysosomal storage disease
Industries: Medical Practice, Startups
Technologies: ultragenyx.com is using 7 Technologies.
Social Media: ultragenyx.com has 14 social media shares and likes.
We have 5 emails for ultragenyx.com.
Verified Contacts from
Web Server Technology
Similar Medical Practice Companies
These are contacts we've discovered through publicly available sources and might be outdated.
Use our PerfectLink™ Contact Finder to verify contacts.
Additional Info and Employees
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Sign up to get full access to all the ultragenyx.com emails we have.
Find emails for ultragenyx.com executives, including the Chief Executive Officer, Chief Financial Officer, and Chief Marketing Officer.
Note: Only company contact information will be added. To discover and add individual contacts to My Prospects, please click though to the Company Profile page.